Article
MTMR14 as a novel prognostic predictor and potential immunotherapy target in uveal melanoma
2023-09-06
Abstract excerpt
<h4>Background: </h4> Uveal melanoma (UM) is the most prevalent primary aggressive intraocular tumor, often exhibiting low immunogenicity. Therefore, identifying novel immune-related therapeutic targets for UM are crucial. <h4>Methods: </h4>: The public bioinformatics database was used to comprehensively examine the link between MTMR14 expression, immune checkpoint blockade molecules, and the clinical data of pat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b4f71b71-5b1a-5334-a67f-caa276e5656b
- DOI
- 10.21203/rs.3.rs-3262955/v1
